DY vs. AXSM
DY (Dycom Industries, Inc.) and AXSM (Axsome Therapeutics, Inc.) are both stocks. DY operates in Engineering & Construction (Industrials), while AXSM operates in Biotechnology (Healthcare). Over the past 10 years, DY returned 15.82%/yr vs 39.83%/yr for AXSM. Their 0.21 correlation means their historical movements had little consistent relationship.
Performance
DY vs. AXSM - Performance Comparison
Loading charts...
Returns By Period
The year-to-date returns for both investments are quite close, with DY having a 18.69% return and AXSM slightly higher at 19.36%. Over the past 10 years, DY has underperformed AXSM with an annualized return of 15.82%, while AXSM has yielded a comparatively higher 39.83% annualized return.
DY
- 1D
- -3.85%
- 1M
- -14.76%
- 6M
- 10.07%
- YTD
- 18.69%
- 1Y
- 49.20%
- 3Y*
- 58.45%
- 5Y*
- 42.03%
- 10Y*
- 15.82%
- ALL TIME*
- 13.01%
AXSM
- 1D
- -7.10%
- 1M
- -9.42%
- 6M
- 18.31%
- YTD
- 19.36%
- 1Y
- 115.02%
- 3Y*
- 41.26%
- 5Y*
- 35.01%
- 10Y*
- 39.83%
- ALL TIME*
- 34.71%
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
| $153.10M | $171.36M | $209.26M | |
| $195.20M | $192.79M | $262.31M |
DY vs. AXSM - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
DY Dycom Industries, Inc. | 18.69% | 94.13% | 51.24% | 22.96% | -0.17% | 24.15% | 60.17% | -12.75% | -51.50% | 38.78% |
AXSM Axsome Therapeutics, Inc. | 19.36% | 115.86% | 6.31% | 3.19% | 104.16% | -53.63% | -21.18% | 3,565.25% | -49.64% | -17.04% |
Correlation
The correlation between DY and AXSM is 0.18, which is low. Their historical price movements had little consistent relationship.
| Correlation | |
|---|---|
Correlation (1Y) Focuses on recent behavior, but can change the most. | 0.18 |
Correlation (3Y) Balances recent behavior with more history. | 0.18 |
Correlation (5Y) Shows whether the relationship held over a longer period. | 0.20 |
Correlation (10Y) Provides a long-term view across more market conditions. | 0.21 |
Correlation (All Time) Calculated using the full available price history since Nov 19, 2015 | 0.21 |
Fundamentals
DY:
$12.04B
AXSM:
$11.22B
DY:
$10.48
AXSM:
-$3.72
DY:
1.91
AXSM:
15.58
DY:
6.43
AXSM:
204.46
DY:
$6.25B
AXSM:
$708.24M
DY:
$1.23B
AXSM:
$655.82M
DY:
$1.07B
AXSM:
-$172.72M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
DY vs. AXSM — Risk / Return Rank
DY
AXSM
DY vs. AXSM - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Dycom Industries, Inc. (DY) and Axsome Therapeutics, Inc. (AXSM). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| DY | AXSM | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.71 | ||
| Sortino ratioReturn per unit of downside risk | -2.17 | ||
| Omega ratioGain probability vs. loss probability | 1.21 | 1.47 | -0.26 |
| Calmar ratioReturn relative to maximum drawdown | 1.62 | 6.25 | -4.63 |
| Martin ratioReturn relative to average drawdown | 4.91 | 18.02 | -13.11 |
Loading charts...
Drawdowns
DY vs. AXSM - Drawdown Comparison
The maximum DY drawdown since its inception was -93.54%, which is greater than AXSM's maximum drawdown of -86.65%. Use the drawdown chart below to compare losses from any high point for DY and AXSM.
Loading charts...
Drawdown Indicators
| DY | AXSM | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -93.54% | -86.65% | -6.89% |
Max Drawdown (1Y)Largest decline over 1 year | -30.51% | -18.50% | -12.01% |
Max Drawdown (3Y)Largest decline over 3 years | -32.58% | -32.69% | +0.11% |
Max Drawdown (5Y)Largest decline over 5 years | -33.70% | -61.08% | +27.38% |
Max Drawdown (10Y)Largest decline over 10 years | -89.01% | -81.26% | -7.75% |
Current DrawdownCurrent decline from peak | -25.06% | -14.57% | -10.49% |
Average DrawdownAverage peak-to-trough decline | -45.56% | -39.06% | -6.50% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 10.06% | 6.41% | +3.65% |
Volatility
DY vs. AXSM - Volatility Comparison
Dycom Industries, Inc. (DY) has a higher volatility of 19.81% compared to Axsome Therapeutics, Inc. (AXSM) at 14.94%. This indicates that DY's price experiences larger fluctuations and is considered to be riskier than AXSM based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| DY | AXSM | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 19.81% | 14.94% | +4.87% |
Volatility (6M)Calculated over the trailing 6-month period | 42.94% | 28.72% | +14.22% |
Volatility (1Y)Calculated over the trailing 1-year period | 50.41% | 42.96% | +7.45% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 44.18% | 70.11% | -25.93% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 53.32% | 90.38% | -37.06% |
Dividends
DY vs. AXSM - Dividend Comparison
Neither DY nor AXSM has paid dividends to shareholders.
Financials
DY vs. AXSM - Financials Comparison
This section allows you to compare key financial metrics between Dycom Industries, Inc. and Axsome Therapeutics, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
DY vs. AXSM - Profitability Comparison
DY - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, Dycom Industries, Inc. reported a gross profit of 275.08M and revenue of 1.96B. Therefore, the gross margin over that period was 14.0%.
AXSM - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, Axsome Therapeutics, Inc. reported a gross profit of 176.48M and revenue of 191.20M. Therefore, the gross margin over that period was 92.3%.
DY - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, Dycom Industries, Inc. reported an operating income of 143.75M and revenue of 1.96B, resulting in an operating margin of 7.3%.
AXSM - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, Axsome Therapeutics, Inc. reported an operating income of -63.36M and revenue of 191.20M, resulting in an operating margin of -33.1%.
DY - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, Dycom Industries, Inc. reported a net income of 91.29M and revenue of 1.96B, resulting in a net margin of 4.7%.
AXSM - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, Axsome Therapeutics, Inc. reported a net income of -64.54M and revenue of 191.20M, resulting in a net margin of -33.8%.
Frequently Asked Questions
DY and AXSM have a correlation of 0.18, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
DY has higher volatility (19.81%) compared to AXSM (14.94%). In terms of maximum drawdown, DY dropped -93.54% vs AXSM's -86.65%.
AXSM currently has the higher Sharpe Ratio (2.69 vs 0.98), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for DY and AXSM
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer